Newgen Software Technologies Limited (NEWGEN)
Enclosed transcript of Conference Call Q1''27
AI summary
- Q1 FY27 revenue 357cr +11% y-y; annuity revenue 254cr +14% y-y; SaaS/license subscription 60cr +40% y-y
- EBITDA 56cr (15.7% margin); PAT 63cr +26% y-y (17.6% margin)
- U.S. revenue grew 27%, India 96cr, EMEA 114cr, APAC 56cr; 10 new logos added
- AI capabilities integrated across verticals; AI product pricing evolving with customer acceptance
- Implementation revenue down due to project delays, expected recovery in Q2/Q3
- Management change: Tarun Nandwani appointed CEO effective Aug 1, 2026
- Pipeline strong in India and EMEA; focus on large deals and subscription growth
- R&D spend ~9% of revenue; margin expansion driven by AI-driven operational efficiencies
- No revenue guidance; expect double-digit growth and margin expansion for FY27
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 NEWGEN — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add NEWGEN to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Newgen Software Technologies Limited
Important.
The summary above is generated automatically from Newgen Software Technologies Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.